Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03608579 · ClinicalTrials.gov registry record · Phase 1
Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA
A Phase 1 study of Osteoarthritis, Hip, sponsored by Mayo Clinic.
- Active
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03608579 is a Phase 1 study of Osteoarthritis, Hip that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 1,272-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03608579, a Phase 1 study of Osteoarthritis, Hip, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Will injection(s) of autologous culture-expanded AMSCs be safe and efficacious for treatment of painful Hip OA, and if so, which dosing regimen is most effective?
Conditions Studied
Interventions
- DRUG Autologous Adipose Derived Mesenchymal Stromal Cells
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2026-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03608579
The ClinicalTrials.gov registry entry for NCT03608579 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,272-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention - of which Autologous Adipose Derived Mesenchymal Stromal Cells is the first listed.
NCT03608579 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03608579 about?
NCT03608579 is a clinical study titled "Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA". Will injection(s) of autologous culture-expanded AMSCs be safe and efficacious for treatment of painful Hip OA, and if so, which dosing regimen is most effective?
What is the current status of trial NCT03608579?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2018-11-05. Estimated completion is 2026-12.
What conditions does trial NCT03608579 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip.
What interventions are being tested in trial NCT03608579?
The interventions under investigation include: Autologous Adipose Derived Mesenchymal Stromal Cells (DRUG).
Who is sponsoring clinical trial NCT03608579?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03608579 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acetabular Shell Positioning Using Patient Specific Instruments
COMPLETED · Phase 1
-
To Assess the Patients' Ability to Self-Administer Fasinumab
COMPLETED · Phase 1
-
Safety and Effectiveness of the HIT Reverse HRS
RECRUITING · NA
-
Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee
RECRUITING
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.